carlobifulco

[Faisal Mahmood @AI4Pathology]

For the past 5 years, our CLAM toolbox has been widely used by the community for whole-slide image (WSI) processing. For scalability, today we are excited to announce the release of two major internally developed open libraries for large scale batch processing of pathology WSIs and foundation model benchmarking: Trident (https://t.co/J2dfveHYjC) and Patho-Bench (https://t.co/DfeFTwCZPM).

Read the excellent blog from our superstar grad student Andrew Zhang @aspartate_ai explaining why we built these tools and how you can benefit and contribute: https://t.co/6MEqggo6nf

Trident includes,
- Computationally efficient tools for handling very large scale batch processing of WSI maximizing GPU and CPU compute.
- Support for all SOTA patch-level and slide level foundation models, including latest foundation models from our group UNI 2 (https://t.co/5Gkyzd8R8a) and TITAN (https://t.co/MyoVWlRu1a).

Patho-Bench includes,
- A large benchmark to standardize evaluation of pathology FMs curated from publicly available data, featuring 42 clinically relevant tasks (including disease subtyping, grading, treatment response, survival/outcome prediction, IHC scoring, biomarker and molecular alteration prediction).
- Experiment handlers for running all combination of modeling choices and tasks including linear probing, survival, etc.
- The ability to run hundreds of experiments using a single command, with automatic GPU load-balancing, experiment monitoring, and results collection.
Preprint: https://t.co/0OQzzPD7rC
Congrats to @aspartate_ai, @GuillaumeJaume , @anurag_vaidya7, and the rest of the team! Stay tuned for more to come soon.

[Dr. Jasmine Plummer 👩🏻‍🔬🧬🇨🇦🇺🇸 @DrJasPlummer]

Can’t wait to get my #multiomics2024 swag!!! If you haven’t registered you are missing out… all the fun #singlecell #spatial #multiomics peeps will be there

[Arutha K @aruthak]

Don't miss out on https://t.co/E99Gms3Aml from December 1-3! Join over 50 top industry and academic experts as they share groundbreaking insights in #omics, #spatial, #cancer, and #immunology. Be part of the conversation and expand your knowledge!

[Society for Immunotherapy of Cancer @sitcancer]

Don't miss the 2024 Multi-omics Meeting Dec. 1–3 in QLD, Australia! Engage with global researchers and understand digital pathology and omics-based deep tissue profiling. View agenda and register now: https://t.co/r06nrmyyLf
@carlobifulco @JoeYeong @BcellBruno

[Society for Immunotherapy of Cancer @sitcancer]

Discover how multi-omics is revolutionizing disease biology! Join the 2024 Multi-omics Meeting Dec. 1–3 in QLD, Australia and view the latest in and omics-based tissue and liquid biopsy profiling. Abstract submissions due Aug. 2. Learn more: https://t.co/9CbG1BVaBI
@carlobifulco

[R. Bryan Bell, MD, DDS, FACS, FRCS(Ed) @rbryanbell]

FDA Approves 1st Cellular Therapy to Treat Patients w Metastatic Melanoma. Testament to the vision of Dr. Steven Rosenberg & many @NCI_CCR_SB who stood on his shoulders, including our own @BrendanCurtiMD @BernardAFox @WalterUrba & Eric Tran @ChilesResearch
https://t.co/2Z9pR0Es0d

[Kevin Keegan @keegan_ke]

Back at @ASCO, check out the @illumina abstracts. https://t.co/GgMjKBQLQ8

[Abcam @abcam]

Last chance to register:

#spatialbiology #progresshappenstogether #singapore @astar_research @ASTARsg

[Jim Mansfield @JimMansfieldYWG]

This is going to be an excellent meeting!

[Bernard A Fox @BernardAFox]

💥 GREAT START TO FRIDAY! Dr Brian Piening of @LabPiening @ChilesResearch @ProvHealth is presenting @ EACRI Lab Mtg on “Multi-Omic Interrogation of the #Tumor #Immune Micro Environment” using latest tech #FinishCancer @illumina @nanostringtech @lunaphore /Thanks @MurdockTrust

[Bernard A Fox @BernardAFox]

@LabPiening @alexadowdell 💥At #AMP22 ? checkout what @LabPiening Gurus & collaborators @carlobifulco @romleidner @WalterUrba Dr Eric Tran & more @ChilesResearch @ProvHealth @providence @illumina are doing to accelerate #research, improve how #patients are treated & #FinishCancer @RodHochmanMD #Genomics

[carlobifulco @carlobifulco]

https://t.co/5c1vV74ftX

[R. Bryan Bell, MD, DDS, FACS, FRCS(Ed) @rbryanbell]

Another huge win for Neoadjuvant immunotherapy: relatlimab + nivolumab in melanoma. The combo resulted in pCR=57%; OPR=70%. Any path response correlated w 1 & 2 yr RFS of 100% & 92%, compared to 88% & 55% for those without (P = 0.005). ⁦@NatureMedicine https://t.co/zoHB7P2PBl

[Eric Topol @EricTopol]

Towards drugging the undraggable in cancer: progress is being made vs KRAS, mutated in 1/4 cancers, but we're not there yet for its most common mutation (G12D)
https://t.co/Nkr2IpqB4G
feature @Nature by @heidiledford

[Faisal Mahmood @AI4Pathology]

Excited to share our @Cancer_Cell review on #AI-driven multimodal data integration in #oncology. We discuss methods, and app. of multimodal data fusion, interconnection, assoc. disc. & more. @BWHPath @MGHPathology @harvard_data @broadinstitute
Link: https://t.co/9WauAudpeF 1/2

[Bernard A Fox @BernardAFox]

Dr. Luigi Nezi @ istituto europeo di oncologica in Milan / Whirlwind intro to #microbiota / Brilliant work! / @NIBITSIENA #ThinkTank - slides coming very fast #cancer #immunotherapy @JenWargoMD @carlobifulco #finishcancer #microbiome

[Phillip Febbo, MD @PhilFebboMD_CMO]

It’s critical that #cancer patients have access to #BioMarkerTesting. These are validated tests with proven clinical utility in today’s complicated healthcare system and are essential in the #precisiononcology era. @ACSCAN

https://t.co/YlzedxR9Lo

[Ibrahim @ialhusseini]

@#Human genome sequencing now costs less than $240. That work cost $100 million just 21 years ago.

@illumina